Lipella Pharmaceuticals (LIPO) Cash Funds per Share

Symbol and logo of brand Lipella Pharmaceuticals (LIPO)

Lipella Pharmaceuticals (LIPO) adheres to standard environmental safety regulations across its offices and laboratories. The staff of specialized professionals is drawn by the opportunity for deep research in the field of urology. Growth prospects depend on licensing agreements and FDA approval for new cystitis treatments. The dynamics of cash per share help assess the business's intrinsic value, with 0.00 recorded as the baseline value.

LIPO - Lipella Pharmaceuticals, Inc. Cash per Share over the range 04/28/2023 - 07/19/2025

Analytical breakdowns for Lipella Pharmaceuticals

- market price and analyst price targets:
- market capitalization details:
- cash and cash flow data:
Summary company analysis:Lipella - LIPO
Flagship merchandise of Lipella Pharma

Cash per share determines the portion of liquid capital attributable to a single security. By analyzing fluctuations in cash per share, an investor assesses the real value of assets relative to the market price. This metric measures the company's margin of safety by excluding illiquid balance sheet items. For Lipella Pharmaceuticals (LIPO), this reserve is critically important for funding R&D laboratories. Maintaining a cash cushion ensures stable engagement with contract manufacturing organizations for therapeutic solutions.

Key competitors

Cash on Hand per Share Haleon Corp HLN|Cash per Single Share KVUE (Kenvue Health)|Verona Pharma plc - Cash Funds per Single Share|Jyong Biotech - Cash per Single Share|LGND: Cash Funds per Single Share|AMRX: Cash per Single Share|Cash on Hand per Share Perrigo Company plc|ALVO: Cash per Share|Liquidia (LQDA) - Cash per Share|Cash Funds per Share Galapagos N.V.|Cash per Single Share ANI Pharmaceuticals, Inc. (ANIP)|Cash per Share MNKD|AMPH (Amphastar Corp) - Amount of Cash per Share|Cash Funds per Share pacira.com PCRX|SPRY - Cash per Single Share|Theravance Biopharma, Inc. - Cash per Share|Amount of Cash per Share AQST (Aquestive Therapeutics, Inc.)|SCPH: Cash per Share|Tectonic Therapeutic Inc. - Amount of Cash per Share|TNXP (Tonix Pharma) - Cash per Share|SXTC: Amount of Cash per Share|Cash per Share EPRX|BHST - Cash on Hand per Share|eXoZymes - Cash per Single Share|Cash per Share oramed.com ORMP|ENTX - Cash Funds per Share|Cash Funds Calculated per Share MindWalk Holdings HYFT|ABVC: Cash per Share|Cash per Single Share Cumberland Pharmaceuticals Inc.|Cash Funds per Share Quantum BioPharma Limited|FGEN: Amount of Cash per Share|Cash per Share TELO|Rani Therapeutics Holdings, Inc. - Cash Funds per Single Share|Cash Funds per Share Synergy CHC Corp. SNYR|Amount of Cash per Share RLYB|LEXX: Cash per Single Share|Amount of Cash per Share PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Cash Funds per Share|Cash per Single Share Aptorum|Cash per Single Share LYRA|Impact BioMedical Inc - Cash Money per Share|Cash per Share TNFA|YCBD - Cash on Hand per Share|PainReform Ltd. - Cash per Single Share|CYTO (Auris Medical) - Cash Money per Share|OptiNose - Cash per Share|Cash Money per Share PIRS|PROC: Cash per Share|Petros - Amount of Cash per Share|Cash per Single Share QLI|SLRN: Amount of Cash per Share|Cash per Single Share TFFP (TFF Pharmaceuticals, Inc.)